首页> 美国卫生研究院文献>Current Developments in Nutrition >Impact of Sugar Reduction and PNPLA3 Genotype on Liver Fat Liver Fibrosis and Body Composition in Hispanic Youth With Obesity: A Randomized Controlled Trial
【2h】

Impact of Sugar Reduction and PNPLA3 Genotype on Liver Fat Liver Fibrosis and Body Composition in Hispanic Youth With Obesity: A Randomized Controlled Trial

机译:肥胖对肝脂肝纤维化和人体组成的糖减少和PNPLA3基因型的影响:随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pediatric Non-Alcoholic Fatty Liver Disease is prevalent among Hispanics, which may partially result from a higher frequency of the C > G polymorphism in the patatin-like phospholipase 3 (PNPLA3) gene. Our prior work showed an interaction between the GG genotype and high dietary sugar, resulting in higher liver fat. Additionally, studies show that extreme sugar depletion improves liver fat in children with obesity. This trial aimed to test whether a clinical intervention for sugar reduction versus standard diet advice in Hispanic youth differentially impacts liver fat, liver fibrosis, body weight and composition, and whether effects differed by PNPLA3 genotype.
机译:儿科非酒精性脂肪肝病在西班牙裔中普遍存在,其可能是由帕托汀样磷脂酶3(PNPLA3)基因中的C> G多态性的较高频率的频率。我们的现有工作表明,GG基因型和高膳食糖之间的相互作用,导致肝脏更高。此外,研究表明,极端糖耗尽改善了肥胖症的肝脏脂肪。该试验旨在测试西班牙裔青年中糖减少与标准饮食建议的临床干预差异地影响肝脂肪,肝纤维化,体重和组成,以及是否有效期不同的PNPLA3基因型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号